4th Quarter - Report — AMEDISYS, INC. for AMEDISYS, INC. (2019)

Firm

AMEDISYS, INC.

Client

AMEDISYS, INC.

Income

—

Expenses

$240,000

Expense method

A: Lobbying Disclosure Act definitions

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Issues related to Centers for Medicare & Medicaid Services policy and issues impacting Medicare/Medicare Advantage and related issues for home health and hospice; issues related to the Bipartisan Budget Act of 2018; H.R. 2573/S. 433 - Home Health Payment Innovation Act of 2019; CMMI Home Health Value Based Purchasing Demonstration; CMMI Value Based Insurance Design Demonstration; S. 296/H.R. 2150 - Home Care Planning & Improvement Act; S. 2080/H.R. 647 - Enhance Palliative and Hospice Education and Training Act; S. 1190/H.R. 2594 - Rural Access to Hospice Act 2019; S. 1725/H.R. 3127 - Home Health Flexibility Act 2019; S. 2807 - Hospice Care Improvement Act of 2019.

Lobbyist	Covered position, as disclosed
DAVE KEMMERLY	—
SCOTT M. LEVY	—

Contacted: Centers For Medicare and Medicaid Services (CMS); Office of Management & Budget (OMB); SENATE; Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES

Bills named: H.R. 3127 (116th), H.R. 2594 (116th), S. 433 (116th), S. 296 (116th), H.R. 647 (116th), S. 2080 (116th), S. 1190 (116th), S. 2807 (116th), H.R. 2150 (116th), H.R. 2573 (116th), S. 1725 (116th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.